As the inflammatory responses in ALN patients are more severe than those in APN patients (higher CRP levels, longer fever duration after antibiotic treatment), these findings suggest that the genetic variant in TLR-2 (rs3804100, T1350C) may protect the host from severe urinary tract infections as ALN. The gene discussed is CRP; the disease is urinary tract infection.